Implementing a Screening Tool for Identifying Patients at Risk for Hereditary Breast and Ovarian Cancer: A Statewide Initiative-Reference-Cited by-同舟云学术

Implementing a Screening Tool for Identifying Patients at Risk for Hereditary Breast and Ovarian Cancer: A Statewide Initiative

Published:2014-07-22 Issue:10 Volume:21 Page:3342-3347
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Brannon Traxler L.,Martin Monique L.,Kerber Alice S.,Bellcross Cecelia A.,Crane Barbara E.,Green Victoria,Matthews Roland,Paris Nancy M.,Gabram Sheryl G. A.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-014-3921-1.pdf

Reference13 articles.

1. U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med. 2005;143:355–61.

2. Berry DA, Iversen ES Jr, Gudbjartsson DR, Hiller EH, Garber JE, Peshkin BN, et al. BRACPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol. 2002;20:2701–12.

3. Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med. 2004;23:1111–30.

4. Antoniou AC, Pharoah PP, Smith P, Easton DF. The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer. 2004;91:1580–90.

5. Teller P, Hoskins KF, Zwaagstra A, Stanislaw C, Iyengar R, Green VL, et al. Validation of the Pedigree Assessment Tool (PAT) in families with BRCA1 and BRCA2 mutations. Ann Surg Oncol. 2010;17:240–6.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mapping inter-professional collaboration in oncogenetics: Results from a scoping review;Critical Reviews in Oncology/Hematology;2024-07

2. Challenges to genetic testing for germline mutations associated with breast cancer among African Americans;Cancer Treatment Reviews;2024-03

3. A Scoping Review of Personalized, Interactive, Web-Based Clinical Decision Tools Available for Breast Cancer Prevention and Screening in the United States;MDM Policy & Practice;2024-01

4. Advancing health equity: A qualitative study assessing barriers and facilitators of implementing hereditary breast and ovarian cancer risk screening tools in community‐based organizations;Journal of Genetic Counseling;2023-04-16

5. Testing a deliberative democracy method with citizens of African ancestry to weigh pros and cons of targeted screening for hereditary breast and ovarian cancer risk;Frontiers in Public Health;2022-11-08